Abstract
Congenital cytomegalovirus (CMV) infection is the most common infection in newborns worldwide and causes hearing loss and other neurological disability in 15–20% of infected infants. Only about half of the hearing loss resulting from congenital CMV infection is currently detected by universal newborn hearing screening because of late-onset hearing loss. Thus, much of the hearing loss and the majority of other CMV-associated disabilities remain undetected for years after birth and are never connected to CMV infection. Congenital CMV may be appropriate to include in national newborn screening (NBS) programs because it is more common than other disorders tested for by NBS programs and is a major cause of disability. Significant obstacles to the implementation of screening for congenital CMV include the lack of a standardized, high-throughput screening test and a protocol for follow-up of CMV-infected children. Nonetheless, screening newborns for congenital CMV infection merits further consideration.
Similar content being viewed by others
References
Andermann A, Blancquaert I et al (2008) Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ 86(4):317–319
Atkinson C, Walter S et al (2009) Use of stored dried blood spots for retrospective diagnosis of congenital CMV. J Med Virol 81(8):1394–1398
Auray-Blais C, Cyr D et al (2007) Quebec neonatal mass urinary screening programme: from micromolecules to macromolecules. J Inherit Metab Dis 30(4):515–521
Balcarek KB, Warren W et al (1993) Neonatal screening for congenital cytomegalovirus infection by detection of virus in saliva. J Infect Dis 167(6):1433–1436
Barbi M, Binda S et al (1996) Diagnosis of congenital cytomegalovirus infection by detection of viral DNA in dried blood spots. Clin Diagn Virol 6(1):27–32
Barbi M, Binda S et al (2006) Diagnosis of congenital CMV infection via dried blood spots. Rev Med Virol 16(6):385–392
Barbi M, MacKay WG et al (2008) External quality assessment of cytomegalovirus DNA detection on dried blood spots. BMC Microbiol 8:2
Boppana SB, Fowler KB et al (2005) Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 146(6):817–823
Boppana S, Ross SA et al (2010) Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA 303:1375–1382
Cannon MJ, Davis KF (2005) Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 5:70
Chakravarti A, Kashyap B et al (2009) Cytomegalovirus infection: an Indian perspective. Indian J Med Microbiol 27(1):3–11
Choi KY, Schimmenti LA et al (2009a) Detection of cytomegalovirus DNA in dried blood spots of minnesota infants who do not pass newborn hearing screening. Pediatr Infect Dis J 28(12):1095–1098
Choi SM, Lee DG et al (2009b) Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp 65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients. J Korean Med Sci 24(4):571–578
Demmler GJ (2005) Screening for congenital cytomegalovirus infection: a tapestry of controversies. J Pediatr 146(2):162–164
Demmler GJ, Buffone GJ et al (1988) Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J Infect Dis 158(6):1177–1184
Distefano AL, Alonso A et al (2004) Human cytomegalovirus: detection of congenital and perinatal infection in Argentina. BMC Pediatr 4:11
Dollard SC, Grosse SD et al (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17(5):355–363
Engman ML, Malm G et al (2008) Congenital CMV infection: prevalence in newborns and the impact on hearing deficit. Scand J Infect Dis 40(11–12):935–942
Foulon I, Naessens A et al (2008) A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J Pediatr 153(1):84–88
Fowler KB, Stagno S et al (1993) Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980–1990. J Infect Dis 168(3):552–556
Fowler KB, Dahle AJ et al (1999) Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr 135(1):60–64
Geers AE (2004) Speech, language, and reading skills after early cochlear implantation. Arch Otolaryngol Head Neck Surg 130(5):634–638
Grosse SD, Ross DS et al (2008) Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol 41(2):57–62
Gurian EA, Kinnamon DD et al (2006) Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics 117(6):1915–1921
Halwachs-Baumann G, Genser B et al (2002) Human cytomegalovirus load in various body fluids of congenitally infected newborns. J Clin Virol 25(Suppl 3):81–87
Inoue N, Koyano S (2008) Evaluation of screening tests for congenital cytomegalovirus infection. Pediatr Infect Dis J 27(2):182–184
Johansson PJ, Jonsson M et al (1997) Retrospective diagnostics of congenital cytomegalovirus infection performed by polymerase chain reaction in blood stored on filter paper. Scand J Infect Dis 29(5):465–468
Just-Nubling G, Korn S et al (2003) Primary cytomegalovirus infection in an outpatient setting–laboratory markers and clinical aspects. Infection 31(5):318–323
Kennedy CR, McCann DC et al (2006) Language ability after early detection of permanent childhood hearing impairment. N Engl J Med 354(20):2131–2141
Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17(4):253–276
Kimberlin DW, Lin CY et al (2003) Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143(1):16–25
Lanari M, Lazzarotto T et al (2006) Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 117(1):e76–e83
Ludwig A, Hengel H (2009) Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro Surveill 14(9):26–32
Melish ME, Hanshaw JB (1973) Congenital cytomegalovirus infection. Developmental progress of infants detected by routine screening. Am J Dis Child 126(2):190–194
Morton CC, Nance WE (2006) Newborn hearing screening–a silent revolution. N Engl J Med 354(20):2151–2164
Moyer VA, Calonge N et al (2008) Expanding newborn screening: process, policy, and priorities. Hastings Cent Rep 38(3):32–39
Mussi-Pinhata MM, Yamamoto AY et al (2009) Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis 49(4):522–528
Nicholas JG, Geers AE (2007) Will they catch up? The role of age at cochlear implantation in the spoken language development of children with severe to profound hearing loss. J Speech Lang Hear Res 50(4):1048–1062
Noyola DE, Mejia-Elizondo AR et al (2003) Congenital cytomegalovirus infection in San Luis Potosi, Mexico. Pediatr Infect Dis J 22(1):89–90
Ornoy A, av-Citrin O (2006) Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol 21(4):399–409
Ross SA, Novak Z et al (2009) Cytomegalovirus blood viral load and hearing loss in young children with congenital infection. Pediatr Infect Dis J 28(7):588–592
Scanga L, Chaing S et al (2006) Diagnosis of human congenital cytomegalovirus infection by amplification of viral DNA from dried blood spots on perinatal cards. J Mol Diagn 8(2):240–245
Schleiss MR (2006) Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern? Rev Med Virol 16(2):73–82
Schlesinger Y, Halle D et al (2003) Urine polymerase chain reaction as a screening tool for the detection of congenital cytomegalovirus infection. Arch Dis Child Fetal Neonatal Ed 88(5):F371–F374
Soetens O, Vauloup-Fellous C et al (2008) Evaluation of different cytomegalovirus (CMV) DNA PCR protocols for analysis of dried blood spots from consecutive cases of neonates with congenital CMV infections. J Clin Microbiol 46(3):943–946
Specter S Ed (2000) Clinical virology manual 3rd Edn. Clinical Virology Manual, ASM Press
Stacey PC, Fortnum HM et al (2006) Hearing-impaired children in the United Kingdom, I: Auditory performance, communication skills, educational achievements, quality of life, and cochlear implantation. Ear Hear 27(2):161–186
Therrell B, Lorey F, Eaton R, Frazier D, Hoffman G, Boyle C, Green D, Devine O, Hannon H (2008) Impact of expanded newborn screening–United States, 2006. MMWR Morb Mortal Wkly Rep 57(37):1012–1015
van der Knaap MS, Vermeulen G et al (2004) Pattern of white matter abnormalities at MR imaging: use of polymerase chain reaction testing of Guthrie cards to link pattern with congenital cytomegalovirus infection. Radiology 230(2):529–536
Vauloup-Fellous C, Ducroux A et al (2007) Evaluation of cytomegalovirus (CMV) DNA quantification in dried blood spots: retrospective study of CMV congenital infection. J Clin Microbiol 45(11):3804–3806
Walter S, Atkinson C et al (2008) Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss. Arch Dis Child Fetal Neonatal Ed 93(4):F280–F285
Wilson JM, Jungner YG (1968) Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 65(4):281–393
Yamagishi Y, Miyagawa H et al (2006) CMV DNA detection in dried blood spots for diagnosing congenital CMV infection in Japan. J Med Virol 78(7):923–925
Yamamoto AY, Mussi-Pinhata MM et al (2001) Usefulness of blood and urine samples collected on filter paper in detecting cytomegalovirus by the polymerase chain reaction technique. J Virol Meth 97(1–2):159–164
Yamamoto AY, Mussi-Pinhata MM et al (2006) Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection? J Clin Virol 36(3):228–230
Yoshida H, Kanda Y et al (2009) Cochlear implantation in children with congenital cytomegalovirus infection. Otol Neurotol 30(6):725–730
Acknowledgements
We thank Stephanie Bialek, Krista Biernath, John Eichwald, and Scott Schmid for helpful comments on a previous version of this manuscript, and Toni Roberson for assistance preparing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Rodney Pollitt
Competing interest: None declared.
Rights and permissions
About this article
Cite this article
Dollard, S.C., Schleiss, M.R. & Grosse, S.D. Public health and laboratory considerations regarding newborn screening for congenital cytomegalovirus. J Inherit Metab Dis 33 (Suppl 2), 249–254 (2010). https://doi.org/10.1007/s10545-010-9125-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-010-9125-3